Immutep Limited, a clinical-stage biotechnology company, engages in developing novel LAG-3 Immunotherapy for cancer and autoimmune diseases.
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune ...
HotCopper has news, discussion, prices and market data on IMMUTEP LIMITED. Join the HotCopper ASX share market forum today for free.
View today's IMM share price, options, bonds, hybrids and warrants. View announcements, advanced pricing charts, trading status, fundamentals, ...
Beoordeling
· Review door Simply Wall St
IMM Stock Overview. Immutep Limited, a clinical-stage biotechnology company, engages in developing novel LAG-3 Immunotherapy for cancer and autoimmune diseases.
Beoordeling
(3)
Based on 3 Wall Street analysts offering 12 month price targets for Immutep Ltd in the last 3 months. The average price target is AU$0.88 with a high forecast ...
Immutep Limited (IMM, Prima BioMed Ltd) is a globally active biotechnology company that is a leader in the development of LAG-3 immunotherapeutic products ...
HotCopper has news, discussion, prices and market data on IMMUTEP LIMITED. Join the HotCopper ASX share market forum today for free.
Gerelateerde zoekopdrachten